ArticleJournal of the American Chemical Society2025
Photochemical Pathways and Light-Enhanced Radical Scavenging Activity of 1,8-Dihydroxynaphthalene Allomelanin.
Article in Journal of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Hydroxy-Group Topology as a Molecular Trigger Between Antioxidant and Photosensitizing Properties in Dihydroxynaphthalenes.ACS omega · 2026Article
- Allomelanin: A Promising Alternative to Polydopamine for Bioapplications.Journal of functional biomaterials · 2026Review
- Melanin-Related Materials in Electrochemical Sensors for Monitoring the Environment and Food.Biosensors · 2025Review
- Photothermal Release by Melanin-like Nanoparticles: Biomedical Applications.Journal of functional biomaterials · 2025Review
- Unexplored Mechanisms of Photoprotection: Synergistic Light Absorption and Antioxidant Activity of Melanin.Antioxidants (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Melanins play important roles in nature, particularly in coloration and photoprotection, where interaction with light is essential. Biomimetic melanins represent an advantageous alternative to natural melanin for technological applications, sharing the same unique biocompatibility, as well as optoelectronic properties. Allomelanin, derived from 1,8-dihydroxynaphthalene, has been reported to exhibit even better photoprotective and antioxidant properties than the most studied example of biomimetic melanin, polydopamine. However, the interaction of allomelanin with light remains largely unexplored. Here we report the excited state dynamics of allomelanin in a wide range of time windows from femtoseconds to microseconds to minutes, using different experimental techniques, i.e., ultrafast transient absorption, nanosecond transient absorption, X-band electron paramagnetic resonance and radical quenching assays. We find that the photophysics of allomelanin starkly differs from that of the widely studied polydopamine, with broadband excitonically coupled states funneling the absorbed energy to a lower energy species in less than 1 ps. Independent of the excitation wavelength, a long-lived (>450 μs) photoproduct is populated in ≈24 ps. Quantum chemistry calculations suggest that the photoproduct primarily exhibits the character of localized 1,8-naphthoquinone radical anions. This light-driven increase in the anionic semiquinone-like radical concentration enhances the antioxidant activity of allomelanin. These results suggest that the two mechanisms considered at the basis of photoprotection, light-extinction and antioxidant action, are indeed synergistic in allomelanin and not independent, paving the way for new applications of allomelanin in nanomedicine, photocatalysis, energy conversion and environmental remediation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.